Drawing based on the description in the official product monograph. No photo yet.
“500 mg are White biconvex, film coated capsule shaped tablets, imprinted "C17" on one side contains 500 mg of cefprozil for administration by oral route”
C17 pill
Pill with imprint C17 is white, capsule and has been identified as Cefprozil 500 mg. It is used for bronchitis, sinus infections and ear infections. It is supplied by Auro Pharma Inc.
Sold in Canada
Cefprozil 500 mg
- Brand
- Auro-Cefprozil
- Imprint
- C17
- Strength
- 500 mg
- Used for
- Bronchitis, sinus infections and ear infections
- Color
- White
- Shape
- Capsule / oblong
- Form
- Tablet
- Manufacturer
- Auro Pharma Inc
- Drug class
- Antibiotic (cephalosporin)
- Sold in
- Canada
- DIN
- 02347253
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Cefprozil used for?
Cefprozil is used for bronchitis, sinus infections, ear infections and sore throat (including strep).
- Medicine type
- Antibiotic (cephalosporin)
Official uses from the US prescribing label
Cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
Upper Respiratory Tract:
Pharyngitis/Tonsillitis:
Caused by Streptococcus pyogenes.
NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are not available at present.
Otitis Media:
Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase-producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains). (See CLINICAL STUDIES.)
NOTE: In the treatment of otitis media due to ß-lactamase producing organisms, cefprozil had bacteriologic eradication rates somewhat lower than those observed with a product containing a specific ß-lactamase inhibitor. In considering the use of cefprozil, lower overall eradication rates should be balanced against the susceptibility patterns of the common microbes in a given geographic area and the increased potential for toxicity with products containing ß-lactamase inhibitors.
Acute Sinusitis:
Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains).
Lower Respiratory Tract:
Acute Bacterial Exacerbation of Chronic Bronchitis:
Caused by Streptococcus pneumoniae, Haemophilus influenzae (including ß-lactamase-producing strains), and Moraxella (Branhamella) catarrhalis (including ß-lactamase-producing strains).
Skin and Skin Structure:
Uncomplicated Skin and Skin-Structure Infections:
Caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes. Abscesses usually require surgical drainage.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil tablets and other antibacterial drugs, cefprozil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
From the FDA-approved label on DailyMed (published Nov 17, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows C17.
- It is white, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Auro-Cefprozil by Auro Pharma Inc.
In Canada: prescription only.
Ingredients
Active: Cefprozil
Other pills with imprint C 17
Same imprint, different listing. Check the color, size and maker against your pill.
-
C 17
Aminocaproic Acid 500 mg
White, round, 13 mm
Used for hemorrhage
- C17 Butalbital, Acetaminophen and Caffeine 50 mg / 325 mg / 40 mg White, round, 11 mm Used for headache Schedule III
- C17 Cefprozil 500 mg White, capsule, 18 mm Used for bronchitis and sinus infections
- C17 Cyclobenzaprine Hydrochloride 7.5 mg White, round, 8 mm Used for muscle stiffness (spasticity) and muscle spasms
- C17 Gemfibrozil 600 mg White, oval, 19 mm Used for high cholesterol and high triglycerides
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AC 79
Theophylline 450 mg
White, capsule, 19 mm
Used for asthma
-
AC 78
Theophylline 300 mg
White, capsule, 14 mm
Used for asthma
-
270 80
Atomoxetine 80 mg
Brown & white, capsule, 19 mm
Used for ADHD
-
266 18
Atomoxetine 18 mg
White & yellow, capsule, 19 mm
Used for ADHD
-
265 10
Atomoxetine 10 mg
White, capsule, 19 mm
Used for ADHD
-
ITR 100
Itraconazole 100 mg
White, capsule, 23 mm
Used for vaginal yeast infections and nail fungus
Other Cefprozil pills
- W712 Cefprozil 250 mg White, capsule, 14 mm Used for bronchitis and sinus infections
- 93 1077 Cefprozil 250 mg Orange, round, 10 mm Used for bronchitis and sinus infections
- C16 Cefprozil 250 mg Orange, capsule, 14 mm Used for bronchitis and sinus infections
- LUPIN 250 Cefprozil 250 mg Orange, oval, 15 mm Used for bronchitis and sinus infections
- 244 Cefprozil 250 mg Yellow, oval, 14 mm Used for bronchitis and sinus infections
- RB 41 Cefprozil Monohydrate 250 mg White, oval Used for bronchitis and sinus infections
- LUPIN 500 Cefprozil 500 mg White, oval, 18 mm Used for bronchitis and sinus infections
- W713 Cefprozil 500 mg White, capsule, 19 mm Used for bronchitis and sinus infections